Gu X, Lawrence R, Krieger M
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
J Biol Chem. 2000 Mar 31;275(13):9120-30. doi: 10.1074/jbc.275.13.9120.
The murine class B, type I scavenger receptor (mSR-BI) is a receptor for both high density lipoprotein (HDL) and low density lipoprotein (LDL) and mediates selective, rather than endocytic, uptake of lipoprotein lipid. We have developed a "retrovirus library-based activity dissection" method to generate mSR-BI mutants in which some, but not all, of the activities of this multifunctional protein have been disrupted. This method employs three techniques: 1) efficient in vitro cDNA mutagenesis (here error-prone PCR was used), 2) efficient retroviral delivery and high expression of single mutant cDNAs into individual cells, and 3) isolation of infected cells expressing the desired mutant phenotype using high sensitivity positive/negative screening by two-color fluorescence-activated cell sorting. A set of mutants, all having arginine substitutions at two common sites (positions 402 or 401 and position 418), were isolated and characterized. Mutation at either site alone did not generate as strong a mutant phenotype (loss of DiI uptake from DiI-HDL) as did the double mutations. "Activity-dissected" double mutants were as effective as wild-type mSR-BI in functioning as LDL receptors, mediating high affinity LDL binding and uptake of metabolically active cholesterol from LDL, but they lost most of their corresponding HDL receptor activity. Thus, these mutants provide support for the proposal that the interaction of SR-BI with HDL differs from that with LDL. Examination of the in vivo function of such mutants may provide insights into the differential roles of the LDL and HDL receptor activities of SR-BI in normal lipoprotein metabolism and in SR-BI's ability to protect against atherosclerosis.
小鼠B类I型清道夫受体(mSR-BI)是高密度脂蛋白(HDL)和低密度脂蛋白(LDL)的受体,介导脂蛋白脂质的选择性摄取而非内吞摄取。我们开发了一种“基于逆转录病毒文库的活性剖析”方法来生成mSR-BI突变体,该多功能蛋白的部分而非全部活性已被破坏。此方法采用三种技术:1)高效的体外cDNA诱变(此处使用易错PCR),2)高效的逆转录病毒递送和单个突变cDNA在单个细胞中的高表达,3)通过双色荧光激活细胞分选进行高灵敏度阳性/阴性筛选,分离出表达所需突变表型的感染细胞。分离并鉴定了一组突变体,所有突变体在两个常见位点(402或401位和418位)都有精氨酸替代。单独在任何一个位点发生突变所产生的突变表型(从DiI-HDL摄取DiI的丧失)都不如双突变强烈。“活性剖析”双突变体在作为LDL受体发挥作用、介导高亲和力LDL结合以及从LDL摄取代谢活性胆固醇方面与野生型mSR-BI一样有效,但它们失去了大部分相应的HDL受体活性。因此,这些突变体为SR-BI与HDL的相互作用不同于其与LDL的相互作用这一观点提供了支持。研究此类突变体的体内功能可能有助于深入了解SR-BI的LDL和HDL受体活性在正常脂蛋白代谢以及SR-BI预防动脉粥样硬化能力中的不同作用。